Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06896695 · ClinicalTrials.gov registry record · NA

A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial

A NA study of Head and Neck Carcinoma, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06896695: Recruiting NA study of Head and Neck Carcinoma, sponsored by Roswell Park Cancer Institute.

NCT06896695 is a NA study of Head and Neck Carcinoma that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 50 participants, below the 412-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06896695, a NA study of Head and Neck Carcinoma, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial compares the effect a financial intervention, called Financial Compass, to usual care in identifying and addressing financial hardship in patients with head and neck cancer. Previous research has shown that head and neck cancer patients experiencing financial hardship have decreased overall and cancer specific survival. Using a financial intervention, Financial Compass, may be more effective than usual care in identifying and addressing financial hardship in patients with head and neck cancer.

Primary Outcome

Will use stage 1A of the National Institutes of Health Stage Model to further develop the Financial Compass intervention. Will use data from in-depth interviews and collaborative engagement of advisory boards to refine the final Financial Compass intervention package. Will complete the Financial Compass intervention package. Will use the Person, Extended Family, Neighborhood (PEN)-3 model to guide integration of stakeholder feedback into the final Financial Compass intervention package. Will pre

Conditions Studied

Interventions

  • OTHER Survey Administration
  • OTHER Best Practice
  • OTHER Discussion
  • OTHER Financial Navigation

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-23
Est. Completion 2027-02-25
Phase NA
Roswell Park Cancer Institute

365 total trials

What NCT06896695 shows while recruiting

NCT06896695 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 412-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.

NCT06896695 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06896695 about?

NCT06896695 is a clinical study titled "A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial". This clinical trial compares the effect a financial intervention, called Financial Compass, to usual care in identifying and addressing financial hardship in patients with head and neck cancer. Previous research has shown that head and neck cancer patients experiencing financial hardship have decrea...

What is the current status of trial NCT06896695?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-23. Estimated completion is 2027-02-25.

What conditions does trial NCT06896695 study?

This clinical trial studies the following conditions: Head and Neck Carcinoma.

What interventions are being tested in trial NCT06896695?

The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), Discussion (OTHER), Financial Navigation (OTHER).

Who is sponsoring clinical trial NCT06896695?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06896695 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06896695's enrollment target sits among peer trials

50 14th of 30 higher than 15 of 30 other Head and Neck Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06896695, the US trial registry maintained by the National Library of Medicine. NCT06896695 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.